Company News

As on (17 Jul 2025 | 10:57)
Back To Homepage As on (17 Jul 2025 | 10:57)
Gland Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 543245 ISIN Demat INE068V01023 Book Value 592.09 NSE Symbol GLAND Div & Yield % 0.91 Market Cap (₹ Cr.) 32469.37 P/E 29.8 EPS 66.14 Face Value 1
Date Headline
11-Jul-25 Gland Pharma's Pashamylaram facility receives GMP certification from Danish Medicines Agency
24-Jun-25 Gland Pharma's JNPC facility completes USFDA inspection
04-Jun-25 Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection 2.5 mg/mL
21-May-25 Gland Pharma to hold AGM
20-May-25 Board of Gland Pharma recommends final dividend
07-May-25 Gland Pharma announces board meeting date
30-Apr-25 Gland Pharma receives USFDA approval for Latanoprostene Bunod Ophthalmic Solution
03-Apr-25 Gland Pharma receives USFDA approval for Acetaminophen Injection 10 mg/mL
10-Mar-25 Gland Pharma appoints Wriddhee Maitra as VP - Human Resources
26-Feb-25 Gland Pharma allots 4,700 equity shares under ESOP